# Mallinckrodt clinical trials: 87 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 87 trials with Mallinckrodt as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Mallinckrodt: 87 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/mallinckrodt

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 87
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 25 newest of 87, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 19, 2019 | NCT04169061 | Impact of Acthar on Everyday Life of Participants With Severe Keratitis | Mallinckrodt | Phase 4 | Completed | Keratitis | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04169061) |
| October 16, 2019 | NCT04128462 | MNK-6105 for Patients With Cirrhosis and High Ammonia Levels Affecting Brain Function | Mallinckrodt | Phase 3 | Withdrawn | Hepatic Encephalopathy | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04128462) |
| October 19, 2018 | NCT03712280 | MNK6106 for Liver Disease (Hepatic Cirrhosis) That in the Past Has Affected the Brain (Hepatic Encephalopathy) | Mallinckrodt | Phase 2 | Completed | Hepatic Cirrhosis, Hepatic Encephalopathy (HE) | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03712280) |
| September 4, 2018 | NCT03656692 | Safety and Effectiveness of Acthar Gel for Inflammation of the Eye's Uvea (Middle Layer) | Mallinckrodt | Phase 4 | Terminated | Uveitis, Posterior, Uveitis, Intermediate, Panuveitis | 5 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03656692) |
| October 25, 2017 | NCT03320070 | Acthar Gel in Participants With Pulmonary Sarcoidosis | Mallinckrodt | Phase 4 | Completed | Sarcoidosis, Pulmonary | 55 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03320070) |
| April 27, 2017 | NCT03132428 | Registry to Evaluate INOmax in Newborn Babies With Pulmonary Hypertension | Mallinckrodt | Observational | Terminated | Pulmonary Hypertension of Newborn | 140 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03132428) |
| March 3, 2017 | NCT03068754 | Study of Acthar® Gel (Acthar) for Amyotrophic Lateral Sclerosis (ALS) | Mallinckrodt | Phase 2/3 | Terminated | Amyotrophic Lateral Sclerosis | 143 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03068754) |
| November 17, 2016 | NCT02966860 | Single-Dose PK Study of an Oxycodone/Acetaminophen Solution in Healthy Subjects | Mallinckrodt | Phase 1 | Completed | Healthy Volunteers | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02966860) |
| November 3, 2016 | NCT02953821 | Acthar Gel for Active Systemic Lupus Erythematosus (SLE) | Mallinckrodt | Phase 4 | Completed | Lupus Erythematosus, Systemic | 172 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02953821) |
| September 29, 2016 | NCT02919761 | Safety and Effectiveness of Acthar Gel in Participants With Rheumatoid Arthritis | Mallinckrodt | Phase 4 | Completed | Arthritis, Rheumatoid | 259 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02919761) |
| July 28, 2016 | NCT02848729 | Drug Interactions Between Morphine and Orally or IV Administered Acetaminophen | Mallinckrodt | Phase 4 | Completed | Pain | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02848729) |
| May 12, 2016 | NCT02770716 | Study To Confirm Efficacy and Safety of Terlipressin in Hepatorenal Syndrome (HRS) Type 1 | Mallinckrodt | Phase 3 | Completed | Hepatorenal Syndrome | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02770716) |
| May 10, 2016 | NCT02767349 | Pharmacokinetics and Safety of MNK-155 in Postsurgical Adolescent Subjects With Moderate to Severe Acute Pain | Mallinckrodt | Phase 1 | Withdrawn | Acute Pain | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02767349) |
| April 21, 2016 | NCT02746263 | Multicenter Study to Compare Intravenous and Oral Acetaminophen for the Treatment of Acute Moderate to Severe Pain | Mallinckrodt | Phase 4 | Terminated | Acute Pain, Postoperative | 1 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02746263) |
| February 9, 2016 | NCT02678416 | Reduction in Pain Intensity Following IV or Oral Pain-relieving Products | Mallinckrodt | Phase 4 | Completed | Pain | 79 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02678416) |
| December 17, 2015 | NCT02633033 | Observational Registry of Acthar Gel for Participants With Multiple Sclerosis Relapse | Mallinckrodt | Observational | Completed | Multiple Sclerosis, Relapsing-Remitting | 160 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02633033) |
| September 28, 2015 | NCT02561741 | Pharmacokinetic, Bioavailability, and Safety Study of COV155 Administered in Healthy Subjects Under Fed and Fasted Conditions | Mallinckrodt | Phase 1 | Completed | Pharmacokinetics | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02561741) |
| September 28, 2015 | NCT02561650 | Pharmacokinetic, Bioavailability, and Safety Study of COV155 Administered in Healthy Subjects Under Fed and Fasted Conditions | Mallinckrodt | Phase 1 | Completed | Pharmacokinetics | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02561650) |
| July 27, 2015 | NCT02508935 | Pharmacokinetics (PK) and Safety Study of XARTEMIS® XR in Postsurgical Adolescent Subjects With Moderate to Severe Acute Pain | Mallinckrodt | Phase 4 | Terminated | Acute Pain | 23 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02508935) |
| December 22, 2014 | NCT02321319 | Open-Label Safety and PK Study of ER Hydromorphone Tablets in Opioid-Tolerant Pediatric Chronic Pain Patients | Mallinckrodt | Phase 3 | Terminated | Chronic Pain | 5 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02321319) |
| November 5, 2014 | NCT02284256 | A Safety and Efficacy Study Comparing Fibrocaps and Tachosil in Hepatic Surgery | Mallinckrodt | Phase 3 | Completed | Surgical Bleeding | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02284256) |
| April 17, 2014 | NCT02117349 | Topical Raplixa for Surgical Bleeding in Children | Mallinckrodt | Phase 2 | Terminated | Surgical Bleeding | 55 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02117349) |
| April 15, 2014 | NCT02113735 | Safety and Efficacy Study of Acthar in Subjects With ARDS | Mallinckrodt | Phase 2 | Withdrawn | Acute Respiratory Distress Syndrome | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02113735) |
| January 20, 2014 | NCT02040558 | Trial to Study the Safety of Intravenous MNK-010 in Advanced Solid Tumors | Mallinckrodt | Phase 1 | Terminated | Advanced Solid Tumors | 44 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02040558) |
| November 25, 2013 | NCT01993875 | Pharmacodynamic, Pharmacokinetic, and Tolerability Study of a Liquid Form of Lubiprostone in Adult Subjects With Chronic Idiopathic... | Mallinckrodt | Phase 3 | Completed | Chronic Idiopathic Constipation | 164 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01993875) |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 1 |
| Phase 1 | 17 |
| Phase 1/2 | 2 |
| Phase 2 | 20 |
| Phase 2/3 | 1 |
| Phase 3 | 29 |
| Phase 4 | 12 |
| Not applicable | 2 |
| Observational | 3 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 62 |
| Terminated | 18 |
| Withdrawn | 6 |
| Approved for marketing | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Pain | 10 |
| Pain, Postoperative | 5 |
| Fever | 5 |
| Acute Pain | 4 |
| Chronic Pain | 3 |
| Osteoarthritis | 3 |
| Hypertension, Pulmonary | 3 |
| Lung Diseases | 3 |
| Hepatorenal Syndrome | 3 |
| Arthritis, Rheumatoid | 2 |
| Graft vs Host Disease | 2 |
| Hypoxia | 2 |
| Anemia, Sickle Cell | 2 |
| Postoperative Hemorrhage | 2 |
| Bunion | 2 |
| Renal Insufficiency | 2 |
| ST Elevation Myocardial Infarction | 2 |
| Proteinuria | 2 |
| Nephrotic Syndrome | 2 |
| Amyotrophic Lateral Sclerosis | 2 |
| Multiple Sclerosis | 2 |
| Hepatic Encephalopathy | 2 |
| Osteoarthritis, Knee | 2 |
| Lupus Erythematosus, Systemic | 2 |
| Respiratory Insufficiency | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Telecommunications services in the United States](https://specstream.ai/data/businesses/telecommunications-services/united-states)
- [Computer wholesalers in the United States](https://specstream.ai/data/businesses/computer-wholesalers/united-states)
- [Manufacturers in the United States](https://specstream.ai/data/businesses/manufacturers/united-states)
- [Tree services in the United States](https://specstream.ai/data/businesses/tree-services/united-states)
- [Deck builders in the United States](https://specstream.ai/data/businesses/deck-builders/united-states)
- [Metal plating companies in the United States](https://specstream.ai/data/businesses/metal-plating-companies/united-states)
